Eli Lilly & Co. has halted a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons.
www.bloomberg.com
#Lilly #Halts #Diabetes #Trial #MuscleSparing #Drug #Zepbound
Lilly Halts Diabetes Trial of Muscle-Sparing Drug With Zepbound
